STERIS plc (STE) Q2 2023 Earnings Call Transcript

03:24pm, Thursday, 10'th Nov 2022
STERIS plc (NYSE:STE ) Q2 2023 Results Conference Call November 10, 2022 10:00 AM ET Company Participants Julie Winter - IR Daniel Carestio - President, CEO Michael Tokich - SVP, CFO Conference Call P
Barring AST, poor reported revenue performance across three of STERIS' (STE) operating segments poses concerns.
Steris (STE) delivered earnings and revenue surprises of -0.50% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Both have loyal and long-term customers, as well as plenty of accessible growth for years to come.
DUBLIN, IRELAND, Oct. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quar

What's Driving The Growth For STERIS Stock?

08:00am, Friday, 07'th Oct 2022
STERIS stock (NYSE: STE), a healthcare company focused on infection prevention, has seen a 29% fall this year, slightly underperforming the broader S&P500 index, down 21%.
BioCryst Pharmaceuticals and Steris could both deliver outstanding returns for patient shareholders.
STERIS has been traded down in recent months with sellers driving price action to the downside since April. Despite this, we believe shares still offer compelling value when examining STE's true corpo
Investors are optimistic about STERIS' (STE) robust segmental performance and Cantel Medical buyout.
STERIS plc. (NYSE:STE ) Q1 2023 Earnings Conference Call August 3, 2022 10:00 AM ET Company Participants Julie Winter - Vice President-Investor Relations Mike Tokich - Senior Vice President & Chief Fi

Steris (STE) Meets Q1 Earnings Estimates

07:36pm, Tuesday, 02'nd Aug 2022
Steris (STE) delivered earnings and revenue surprises of 0% and 5.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DUBLIN, IRELAND, July 20, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 first quart
The mean of analysts' price targets for Steris (STE) points to a 29.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i
Steris (STE) possesses solid growth attributes, which could help it handily outperform the market.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE